Lipocine Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
LPCN on Nasdaq
Location
675 Arapeen Drive, Suite 202, Salt Lake City, United States

There are no Buy or Sell transactions made by insiders since 10/19/2024

Lipocine Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mahesh V. Patel Chief Executive Officer, Director $1.29M Jan 2, 2025
Krista Fogarty Principal Accounting Officer $102K Dec 23, 2024
Morgan R. Brown Chief Financial Officer $46.7K Dec 7, 2021
John W. Higuchi Director $36.9K Jun 4, 2025
Richard Dana Ono Director $36.9K Jun 4, 2025
Jeffrey Fink Director $36.9K Jun 4, 2025
George Nomikos Chief Medical Officer $33.2K Nov 1, 2022
Spyros Papapetropoulos Director $23K Jun 4, 2025
Jill M. Jene Director $23K Jun 4, 2025

Recent Insider Transactions by Companies or Individuals for Lipocine Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.